Latin America Cardiac Resynchronization Therapy Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01238874

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Medtronic Latin America (from the registry)
Registry
  • NCT NCT01238874
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01238874. Non-randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Latin America Cardiac Resynchronization Therapy Study
Acronym
LatAmCRT
Condition
Heart Failure.
Intervention (Device)
Cardiac Resynchronization Therapy
Lead sponsor
Medtronic Latin America (class: industry)

Record details

Record id
cardio:ct-nct01238874
Content hash
08b654b3388b910b3401d3b8699a717952916391662c9611f775fa1a80fdb4f1